Tuesday, May 12, 2026

The Medicaid and CHIP Payment and Access Commission (MACPAC) has recommended that CMS and states increase transparency and oversight of AI algorithms used for prior authorization in Medicaid. The commission flagged a lack of clarity around how these AI tools make decisions, which can lead to arbitrary denials and opaque appeal processes. This is a federal-level signal that pressure is mounting on payers to reveal the clinical criteria and logic behind automated review systems, a key friction point for practices managing Medicaid populations. No binding rule is in place, but the recommendation adds weight to provider advocacy for more transparent and auditable systems.

A recent Medicare coding change is causing confusion and claim denials for pharmacies in several states. The report indicates that unclear guidance from CMS or its contractors on the implementation of new codes or modifiers is disrupting the pharmacy billing workflow. This type of administrative ambiguity often leads to cash flow interruptions and increased back-end rework. Pharmacy-based practices and those with integrated dispensaries should immediately audit recent Medicare Part B and D claim rejections related to code changes. Contact your Medicare Administrative Contractor (MAC) for clarification and document any new billing instructions to avoid future denials.

A new analysis finds 99 rural hospitals across five Southern states are at immediate risk of closure following federal Medicaid cuts enacted in H.R. 1. Alabama, Mississippi, Georgia, Tennessee, and South Carolina are the most affected. These closures would eliminate critical access points for patients, disrupt referral networks for specialty practices, and concentrate remaining patient volume into fewer, often distant, facilities. The financial strain stems from a combination of reduced federal Medicaid reimbursements and the impending expiration of key rural hospital support programs in 2027. The Southern Poverty Law Center frames the closures as a direct consequence of recent federal budget decisions, signaling a sustained contraction of the rural healthcare safety net that will reshape local market dynamics for independent practices.

The Department of Labor and HHS issued a proposed rule aimed at helping employers expand fertility benefit coverage under employer-sponsored health plans. The rule seeks to clarify plan design and fiduciary standards to encourage coverage of treatments like in vitro fertilization (IVF) and fertility preservation, which are currently excluded by many plans due to cost and legal complexity. If finalized, this would increase patient demand for fertility services and could prompt payers to adjust medical policy and prior authorization requirements for reproductive medicine codes. The rule is part of a broader administrative effort to address gaps in reproductive healthcare access. Practices in reproductive endocrinology and obstetrics should watch for the rule's publication in the Federal Register and the subsequent comment period to assess potential impacts on covered services and patient eligibility.